Csenge Advisory Group’s Herbalife HLF Stock Holding History

Csenge Advisory Group’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4	Closed	–	–	724
2018 Q3	$0	Buy	+4	New	+$221	﹤0.01%	1262

Other funds holding HLF

Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

DVI

Deccan Value Investors Greenwich, Connecticut $84.6M AUM 57.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Csenge Advisory Group's HLF Position: Q4 2018 in Review

Csenge Advisory Group sold out of Herbalife (HLF) in Q4 2018, closing a stake of 4 shares.

Csenge Advisory Group first reported a position in HLF in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 253 funds tracked by Wall St. Rank hold HLF as of Q4 2018.

Csenge Advisory Group reported no remaining Herbalife position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 4 Herbalife shares in Q4 2018.
Csenge Advisory Group first reported a position in Herbalife in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Herbalife position peaked at $0 in Q3 2018.
253 funds tracked by Wall St. Rank held Herbalife as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.